Annual CFO
-$315.02 M
-$169.09 M-115.87%
December 31, 2023
Summary
- As of February 8, 2025, FGEN annual cash flow from operations is -$315.02 million, with the most recent change of -$169.09 million (-115.87%) on December 31, 2023.
- During the last 3 years, FGEN annual CFO has fallen by -$396.62 million (-486.05%).
- FGEN annual CFO is now -486.05% below its all-time high of $81.60 million, reached on December 31, 2020.
Performance
FGEN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$8.38 M
+$31.49 M+78.99%
September 30, 2024
Summary
- As of February 8, 2025, FGEN quarterly cash flow from operations is -$8.38 million, with the most recent change of +$31.49 million (+78.99%) on September 30, 2024.
- Over the past year, FGEN quarterly CFO has increased by +$9.95 million (+54.28%).
- FGEN quarterly CFO is now -105.60% below its all-time high of $149.66 million, reached on June 30, 2020.
Performance
FGEN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$125.85 M
+$76.16 M+37.70%
September 30, 2024
Summary
- As of February 8, 2025, FGEN TTM cash flow from operations is -$125.85 million, with the most recent change of +$76.16 million (+37.70%) on September 30, 2024.
- Over the past year, FGEN TTM CFO has increased by +$189.17 million (+60.05%).
- FGEN TTM CFO is now -230.96% below its all-time high of $96.10 million, reached on March 31, 2021.
Performance
FGEN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
FGEN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -115.9% | +54.3% | +60.0% |
| 3 y3 years | -486.1% | +54.3% | +60.0% |
| 5 y5 years | -313.7% | +54.3% | +60.0% |
FGEN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -283.1% | at low | at high | +92.4% | -175.3% | +64.0% |
| 5 y | 5-year | -486.1% | at low | -105.6% | +92.4% | -231.0% | +64.0% |
| alltime | all time | -486.1% | at low | -105.6% | +92.4% | -231.0% | +64.0% |
FibroGen Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$8.38 M(-79.0%) | -$125.85 M(-37.7%) |
| Jun 2024 | - | -$39.87 M(-32.8%) | -$202.02 M(-25.9%) |
| Mar 2024 | - | -$59.29 M(+223.6%) | -$272.72 M(-13.4%) |
| Dec 2023 | -$315.02 M(+115.9%) | -$18.32 M(-78.3%) | -$315.02 M(-9.8%) |
| Sep 2023 | - | -$84.54 M(-23.5%) | -$349.21 M(+10.3%) |
| Jun 2023 | - | -$110.57 M(+8.8%) | -$316.56 M(+32.4%) |
| Mar 2023 | - | -$101.59 M(+93.5%) | -$239.05 M(+63.8%) |
| Dec 2022 | -$145.93 M(+77.5%) | -$52.51 M(+1.2%) | -$145.93 M(-1.6%) |
| Sep 2022 | - | -$51.88 M(+56.9%) | -$148.38 M(+184.0%) |
| Jun 2022 | - | -$33.06 M(+290.1%) | -$52.24 M(+14.3%) |
| Mar 2022 | - | -$8.48 M(-84.6%) | -$45.72 M(-44.4%) |
| Dec 2021 | -$82.23 M(-200.8%) | -$54.96 M(-224.2%) | -$82.23 M(+138.4%) |
| Sep 2021 | - | $44.26 M(-266.7%) | -$34.50 M(-56.9%) |
| Jun 2021 | - | -$26.54 M(-41.0%) | -$80.10 M(-183.4%) |
| Mar 2021 | - | -$44.98 M(+522.4%) | $96.10 M(+17.8%) |
| Dec 2020 | $81.60 M(-203.7%) | -$7.23 M(+435.8%) | $81.60 M(+86.4%) |
| Sep 2020 | - | -$1.35 M(-100.9%) | $43.78 M(+148.1%) |
| Jun 2020 | - | $149.66 M(-351.6%) | $17.65 M(-111.0%) |
| Mar 2020 | - | -$59.49 M(+32.0%) | -$160.67 M(+104.1%) |
| Dec 2019 | -$78.70 M | -$45.05 M(+63.9%) | -$78.70 M(+54.0%) |
| Sep 2019 | - | -$27.48 M(-4.1%) | -$51.12 M(+232.2%) |
| Jun 2019 | - | -$28.65 M(-227.5%) | -$15.39 M(-29.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | $22.48 M(-228.7%) | -$21.70 M(-71.5%) |
| Dec 2018 | -$76.14 M(+14.5%) | -$17.46 M(-311.7%) | -$76.14 M(+27.2%) |
| Sep 2018 | - | $8.25 M(-123.6%) | -$59.87 M(-30.8%) |
| Jun 2018 | - | -$34.96 M(+9.4%) | -$86.55 M(+21.3%) |
| Mar 2018 | - | -$31.96 M(+2595.0%) | -$71.34 M(+7.3%) |
| Dec 2017 | -$66.51 M(-1035.7%) | -$1.19 M(-93.6%) | -$66.51 M(-20.7%) |
| Sep 2017 | - | -$18.43 M(-6.7%) | -$83.87 M(+24.8%) |
| Jun 2017 | - | -$19.76 M(-27.2%) | -$67.20 M(+2327.0%) |
| Mar 2017 | - | -$27.14 M(+46.3%) | -$2.77 M(-139.0%) |
| Dec 2016 | $7.11 M(-138.3%) | -$18.55 M(+949.5%) | $7.11 M(-152.1%) |
| Sep 2016 | - | -$1.77 M(-104.0%) | -$13.65 M(-72.7%) |
| Jun 2016 | - | $44.68 M(-358.9%) | -$50.01 M(-886.2%) |
| Mar 2016 | - | -$17.26 M(-56.1%) | $6.36 M(-134.3%) |
| Dec 2015 | -$18.57 M(-182.9%) | -$39.30 M(+3.1%) | -$18.57 M(+512.3%) |
| Sep 2015 | - | -$38.13 M(-137.7%) | -$3.03 M(-175.2%) |
| Jun 2015 | - | $101.05 M(-339.5%) | $4.03 M(-194.8%) |
| Mar 2015 | - | -$42.19 M(+77.5%) | -$4.25 M(-119.0%) |
| Dec 2014 | $22.41 M(-13.5%) | -$23.77 M(-23.5%) | $22.41 M(-51.5%) |
| Sep 2014 | - | -$31.06 M(-133.5%) | $46.18 M(-40.2%) |
| Jun 2014 | - | $92.76 M(-697.6%) | $77.24 M(-597.6%) |
| Mar 2014 | - | -$15.52 M | -$15.52 M |
| Dec 2013 | $25.92 M(-562.4%) | - | - |
| Dec 2012 | -$5.61 M | - | - |
FAQ
- What is FibroGen annual cash flow from operations?
- What is the all time high annual CFO for FibroGen?
- What is FibroGen annual CFO year-on-year change?
- What is FibroGen quarterly cash flow from operations?
- What is the all time high quarterly CFO for FibroGen?
- What is FibroGen quarterly CFO year-on-year change?
- What is FibroGen TTM cash flow from operations?
- What is the all time high TTM CFO for FibroGen?
- What is FibroGen TTM CFO year-on-year change?
What is FibroGen annual cash flow from operations?
The current annual CFO of FGEN is -$315.02 M
What is the all time high annual CFO for FibroGen?
FibroGen all-time high annual cash flow from operations is $81.60 M
What is FibroGen annual CFO year-on-year change?
Over the past year, FGEN annual cash flow from operations has changed by -$169.09 M (-115.87%)
What is FibroGen quarterly cash flow from operations?
The current quarterly CFO of FGEN is -$8.38 M
What is the all time high quarterly CFO for FibroGen?
FibroGen all-time high quarterly cash flow from operations is $149.66 M
What is FibroGen quarterly CFO year-on-year change?
Over the past year, FGEN quarterly cash flow from operations has changed by +$9.95 M (+54.28%)
What is FibroGen TTM cash flow from operations?
The current TTM CFO of FGEN is -$125.85 M
What is the all time high TTM CFO for FibroGen?
FibroGen all-time high TTM cash flow from operations is $96.10 M
What is FibroGen TTM CFO year-on-year change?
Over the past year, FGEN TTM cash flow from operations has changed by +$189.17 M (+60.05%)